INTERMOLECULAR INC 4

Accession 0001311241-13-000245

CIK 0001311241operating

View on SEC.gov Company Profile

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 7:55 PM ET

Size

19.6 KB

Accession

0001311241-13-000245

Insider Transaction Report

Form 4

Period: 2013-12-02

INTERMOLECULAR INCIMI

Chiang Tony P.

Chief Technology Officer

Transactions

Sale
Common Stock, $0.001 par value
2013-12-04$5.48/sh−5,182$28,401→ 76,775 total
Exercise/Conversion
Stock Option (right to buy)
2013-12-02−10,200→ 417,816 total
Exercise: $0.10Exp: 2015-06-14→ Common Stock (10,200 underlying)
Exercise/Conversion
Stock Option (right to buy)
2013-12-04−5,182→ 398,016 total
Exercise: $0.10Exp: 2015-06-14→ Common Stock (5,182 underlying)
Sale
Common Stock, $0.001 par value
2013-12-02$5.55/sh−10,200$56,607→ 76,775 total
Exercise/Conversion
Common Stock, $0.001 par value
2013-12-03$0.10/sh+14,618$1,462→ 91,393 total
Exercise/Conversion
Stock Option (right to buy)
2013-12-03−14,618→ 403,198 total
Exercise: $0.10Exp: 2015-06-14→ Common Stock (14,618 underlying)
Exercise/Conversion
Common Stock, $0.001 par value
2013-12-02$0.10/sh+10,200$1,020→ 86,975 total
Sale
Common Stock, $0.001 par value
2013-12-03$5.51/sh−14,618$80,551→ 76,775 total
Exercise/Conversion
Common Stock, $0.001 par value
2013-12-04$0.10/sh+5,182$518→ 81,957 total

Footnotes (5)

[F1]The sale reported was effected pursuant to a Rule 10b5-1 Sales Plan adopted by Mr. Chiang on May 29, 2013.
[F2]The transaction was executed in multiple trades in prices ranging from $5.41 to $5.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
[F3]The transaction was executed in multiple trades in prices ranging from $5.43 to $5.55, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
[F4]The transaction was executed in multiple trades in prices ranging from $5.4275 to $5.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
[F5]The option was immediately exercisable in full on June 15, 2005; however, the shares vested pursuant to the following schedule: Twenty-five percent (25%) of the shares subject to the original option (1,000,000 shares) vested on the first anniversary measured from May 9, 2005 ("Vesting Commencement Date") and the remaining shares vested in 36 successive equal monthly installments thereafter on each monthly anniversary date of Vesting Commencement Date.

Documents

1 file

4
wf-form4_138620489460407.xmlPrimary
FORM 4

Issuer

INTERMOLECULAR INC

CIK 0001311241

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001311241

Filing Metadata

Form type: 4
Filed: Dec 3, 7:00 PM ET
Accepted: Dec 4, 7:55 PM ET
Size: 19.6 KB

View on SEC.gov